Advertisement
ICUD on Urethral Strictures| Volume 83, ISSUE 3, SUPPLEMENT , S59-S70, March 2014

SIU/ICUD Consultation on Urethral Strictures: Posterior Urethral Stenosis After Treatment of Prostate Cancer

Published:December 20, 2013DOI:https://doi.org/10.1016/j.urology.2013.08.036
      Posterior urethral stenosis can result from radical prostatectomy in approximately 5%-10% of patients (range 1.4%-29%). Similarly, 4%-9% of men after brachytherapy and 1%-13% after external beam radiotherapy will develop stenosis. The rate will be greater after combination therapy and can exceed 40% after salvage radical prostatectomy. Although postradical prostatectomy stenoses mostly develop within 2 years, postradiotherapy stenoses take longer to appear. Many result in storage and voiding symptoms and can be associated with incontinence. The evaluation consists of a workup similar to that for lower urinary tract symptoms, with additional testing to rule out recurrent or persistent prostate cancer. Treatment is usually initiated with an endoscopic approach commonly involving dilation, visual urethrotomy with or without laser treatment, and, possibly, UroLume stent placement. Open surgical urethroplasty has been reported, as well as urinary diversion for recalcitrant stenosis. A proposed algorithm illustrating a graded approach has been provided.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. American Cancer Society. Cancer facts & figures 2010. 2010:23–37. Available at: http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf. Accessed March 30, 2012.

        • Cooperberg M.R.
        • Lubeck D.P.
        • Meng M.V.
        • et al.
        The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
        J Clin Oncol. 2004; 22: 2141-2149
      2. Levels of evidence.
        BJU Int. 2008; 101: 1333
        • Borboroglu P.G.
        • Sands J.P.
        • Roberts J.L.
        • et al.
        Risk factors for vesicourethral anastomotic stricture after radical prostatectomy.
        Urology. 2000; 56: 96-100
        • Hu J.C.
        • Gold K.F.
        • Pashos C.L.
        • et al.
        Role of surgeon volume in radical prostatectomy outcomes.
        J Clin Oncol. 2003; 21: 401-405
        • Erickson B.A.
        • Meeks J.J.
        • Roehl K.A.
        • et al.
        Bladder neck contracture after retropubic radical prostatectomy: incidence and risk factors from a large single-surgeon experience.
        BJU Int. 2009; 104: 1615-1619
        • Carlsson S.
        • Nilsson A.E.
        • Schumacher M.C.
        • et al.
        Surgery-related complications in 1253 robot-assisted and 485 open retropubic radical prostatectomies at the Karolinska University Hospital, Sweden.
        Urology. 2010; 75: 1092-1097
        • Gillitzer R.
        • Thomas C.
        • Wiesner C.
        • et al.
        Single center comparison of anastomotic strictures after radical perineal and radical retropubic prostatectomy.
        Urology. 2010; 76: 417-422
        • Surya B.V.
        • Provet J.
        • Johanson K.E.
        • et al.
        Anastomotic strictures following radical prostatectomy: risk factors and management.
        J Urol. 1990; 143: 755-758
        • Besarani D.
        • Amoroso P.
        • Kirby R.
        Bladder neck contracture after radical retropubic prostatectomy.
        BJU Int. 2004; 94: 1245-1247
        • Dalkin B.L.
        Endoscopic evaluation and treatment of anastomotic strictures after radical retropubic prostatectomy.
        J Urol. 1996; 155: 206-208
        • Gallo L.
        • Perdonà S.
        • Autorino R.
        • et al.
        Vesicourethral anastomosis during radical retropubic prostatectomy: does the number of sutures matter?.
        Urology. 2007; 69: 547-551
        • Srougi M.
        • Paranhos M.
        • Leite K.M.
        • et al.
        The influence of bladder neck mucosal eversion and early urinary extravasation on patient outcome after radical retropubic prostatectomy: a prospective controlled trial.
        BJU Int. 2005; 95: 757-760
        • Ozu C.
        • Hagiuda J.
        • Nakagami Y.
        • et al.
        Radical retropubic prostatectomy with running vesicourethral anastomosis and early catheter removal: our experience.
        Int J Urol. 2009; 16: 487-492
        • Hu J.C.
        • Gu X.
        • Lipsitz S.R.
        • et al.
        Comparative effectiveness of minimally invasive vs open radical prostatectomy.
        JAMA. 2009; 302: 1557-1564
        • Rabbani F.
        • Yunis L.H.
        • Pinochet R.
        • et al.
        Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy.
        Eur Urol. 2010; 57: 371-386
        • Thiel D.D.
        • Igel T.C.
        • Brisson T.E.
        • et al.
        Outcomes with an alternative anastomotic technique after radical retropubic prostatectomy: 10-year experience.
        Urology. 2006; 68: 132-136
        • Levy J.B.
        • Ramchandani P.
        • Berlin J.W.
        • et al.
        Vesicourethral healing following radical prostatectomy: is it related to surgical approach?.
        Urology. 1994; 44: 888-892
        • Elliott S.P.
        • Meng M.V.
        • Elkin E.P.
        • et al.
        Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE.
        J Urol. 2007; 178: 529-534
        • Gonzalgo M.L.
        • Pavlovich C.P.
        • Trock B.J.
        • et al.
        Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy.
        J Urol. 2005; 174: 135-139
        • Crew J.P.
        • Jephcott C.R.
        • Reynard J.M.
        Radiation-induced haemorrhagic cystitis.
        Eur Urol. 2001; 40: 111-123
        • deVries C.R.
        • Freiha F.S.
        Hemorrhagic cystitis: a review.
        J Urol. 1990; 143: 1-9
        • Mate T.P.
        • Gottesman J.E.
        • Hatton J.
        • et al.
        High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.
        Int J Radiat Oncol Biol Phys. 1998; 41: 525-533
        • Aström L.
        • Pedersen D.
        • Mercke C.
        • et al.
        Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer.
        Radiother Oncol. 2005; 74: 157-161
        • Morton G.C.
        The emerging role of high-dose-rate brachytherapy for prostate cancer.
        Clin Oncol (R Coll Radiol). 2005; 17: 219-227
        • Allen Z.A.
        • Merrick G.S.
        • Butler W.M.
        • et al.
        Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.
        Int J Radiat Oncol Biol Phys. 2005; 62: 981-987
        • Zelefsky M.J.
        • Yamada Y.
        • Cohen G.N.
        • et al.
        Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer.
        Int J Radiat Oncol Biol Phys. 2007; 67: 65-70
        • Chen A.B.
        • D'Amico A.V.
        • Neville B.A.
        • et al.
        Patient and treatment factors associated with complications after prostate brachytherapy.
        J Clin Oncol. 2006; 24: 5298-5304
        • Lawton C.A.
        • Bae K.
        • Pilepich M.
        • et al.
        Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of Radiation Therapy Oncology Group studies 85-31, 86-10, and 92-02.
        Int J Radiat Oncol Biol Phys. 2008; 70: 437-441
        • Gardner B.G.
        • Zietman A.L.
        • Shipley W.U.
        • et al.
        Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer.
        J Urol. 2002; 167: 123-126
        • Chism D.B.
        • Horwitz E.M.
        • Hanlon A.L.
        • et al.
        Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement.
        Int J Radiat Oncol Biol Phys. 2003; 55: 71-77
        • Zelefsky M.J.
        • Levin E.J.
        • Hunt M.
        • et al.
        Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
        Int J Radiat Oncol Biol Phys. 2008; 70: 1124-1129
        • MacDonald O.K.
        • Lee R.J.
        • Snow G.
        • et al.
        Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer.
        Urology. 2007; 69: 295-299
        • Cozzarini C.
        • Fiorino C.
        • Di Muzio N.
        • et al.
        Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a phase I-II study.
        Radiother Oncol. 2008; 88: 26-33
        • Merrick G.S.
        • Butler W.M.
        • Lief J.H.
        • et al.
        Temporal resolution of urinary morbidity following prostate brachytherapy.
        Int J Radiat Oncol Biol Phys. 2000; 47: 121-128
        • Martinez A.
        • Gonzalez J.
        • Spencer W.
        • et al.
        Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
        J Urol. 2003; 169: 974-979
        • Merrick G.S.
        • Butler W.M.
        • Wallner K.E.
        • et al.
        Risk factors for the development of prostate brachytherapy related urethral strictures.
        J Urol. 2006; 175: 1376-1380
        • Sullivan L.
        • Williams S.G.
        • Tai K.H.
        • et al.
        Urethral stricture following high dose rate brachytherapy for prostate cancer.
        Radiother Oncol. 2009; 91: 232-236
        • Pellizzon A.C.
        • Salvajoli J.V.
        • Maia M.A.
        • et al.
        Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer.
        J Urol. 2004; 171: 1105-1108
        • Wallner K.
        • Roy J.
        • Harrison L.
        Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.
        J Clin Oncol. 1996; 14: 449-453
        • Merrick G.S.
        • Butler W.M.
        • Tollenaar B.G.
        • et al.
        The dosimetry of prostate brachytherapy-induced urethral strictures.
        Int J Radiat Oncol Biol Phys. 2002; 52: 461-468
        • Seymore C.H.
        • el-Mahdi A.M.
        • Schellhammer P.F.
        The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures.
        Int J Radiat Oncol Biol Phys. 1986; 12: 1597-1600
        • Deger S.
        • Boehmer D.
        • Roigas J.
        • et al.
        High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer.
        Eur Urol. 2005; 47: 441-448
        • Chon B.H.
        • Loeffler J.S.
        The effect of nonmalignant systemic disease on tolerance to radiation therapy.
        Oncologist. 2002; 7: 136-143
        • Grills I.S.
        • Martinez A.A.
        • Hollander M.
        • et al.
        High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
        J Urol. 2004; 171: 1098-1104
        • Lam J.S.
        • Pisters L.L.
        • Belldegrun A.S.
        Cryotherapy for prostate cancer.
        in: Wein A.J. Kavoussi L.R. Novick A.C. Campbell-Walsh Urology. 9th ed. Saunders Elsevier, Philadelphia2007: 3032-3052
        • Koppie T.M.
        • Grossfeld G.D.
        • Miller D.
        • et al.
        Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from the CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
        J Urol. 2000; 164: 81-88
        • Long J.P.
        • Bahn D.
        • Lee F.
        • et al.
        Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate.
        Urology. 2001; 57: 518-523
        • Han K.R.
        • Cohen J.K.
        • Miller R.J.
        • et al.
        Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience.
        J Urol. 2003; 170: 1126-1130
        • Cooper I.S.
        • Hirose T.
        Application of cryogenic surgery to resection of parenchymal organs.
        N Engl J Med. 1966; 274: 15-18
        • Long J.P.
        • Fallick M.L.
        • LaRock D.R.
        • et al.
        Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma.
        J Urol. 1998; 159: 477-484
        • Pisters L.L.
        Cryotherapy for prostate cancer: ready for prime time?.
        Curr Opin Urol. 2010; 20: 218-222
        • Izawa J.I.
        • Ajam K.
        • McGuire E.
        • et al.
        Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer.
        J Urol. 2000; 164: 1978-1981
        • Ahmed H.U.
        • Ishaq A.
        • Zacharakis E.
        • et al.
        Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy.
        BJU Int. 2009; 103: 321-323
        • Challacombe B.J.
        • Murphy D.G.
        • Zakri R.
        • et al.
        High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
        BJU Int. 2009; 104: 200-204
        • Murat F.J.
        • Poissonnier L.
        • Rabilloud M.
        • et al.
        Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
        Eur Urol. 2009; 55: 640-647
        • Chalasani V.
        • Martinez C.H.
        • Lim D.
        • et al.
        Salvage HIFU for recurrent prostate cancer after radiotherapy.
        Prostate Cancer Prostatic Dis. 2009; 12: 124-129
        • Chaussy C.
        • Thüroff S.
        High-intensity focused ultrasound in the management of prostate cancer.
        Expert Rev Med Devices. 2010; 7: 209-217
        • Thüroff S.
        • Chaussy C.
        • Vallancien G.
        • et al.
        High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study.
        J Endourol. 2003; 17: 673-677
        • Madersbacher S.
        • Schatzl G.
        • Djavan B.
        • et al.
        Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia.
        Eur Urol. 2000; 37: 687-694
        • Uchida T.
        • Ohkusa H.
        • Nagata Y.
        • et al.
        Treatment of localized prostate cancer using high-intensity focused ultrasound.
        BJU Int. 2006; 97: 56-61
        • Chaussy C.
        • Thüroff S.
        The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.
        Curr Urol Rep. 2003; 4: 248-252
        • Wei J.T.
        • Calhoun E.
        • Jacobsen S.J.
        Urologic diseases in America project: benign prostatic hyperplasia.
        J Urol. 2005; 173: 1256-1261
        • Lee Y.H.
        • Chiu A.W.
        • Huang J.K.
        Comprehensive study of bladder neck contracture after transurethral resection of prostate.
        Urology. 2005; 65: 498-503
        • Rassweiler J.
        • Seemann O.
        • Schulze M.
        • et al.
        Laparoscopic versus open radical prostatectomy: a comparative study at a single institution.
        J Urol. 2003; 169: 1689-1693
      3. American Urological Association Education and Research, Inc. Results of the treatment outcomes analyses. 2003. Available at: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/bph-management/chapt_3_appendix.pdf. Accessed October 10, 2010.

        • Tan A.
        • Liao C.
        • Mo Z.
        • et al.
        Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction.
        Br J Surg. 2007; 94: 1201-1208
        • Riehmann M.
        • Knes J.M.
        • Heisey D.
        • et al.
        Transurethral resection versus incision of the prostate: a randomized, prospective study.
        Urology. 1995; 45: 768-775
        • Al-Singary W.
        • Arya M.
        • Patel H.R.
        Bladder neck stenosis after transurethral resection of prostate: does size matter?.
        Urol Int. 2004; 73: 262-265
        • Varkarakis J.
        • Bartsch G.
        • Horninger W.
        Long-term morbidity and mortality of transurethral prostatectomy: a 10-year follow-up.
        Prostate. 2004; 58: 248-251
        • Orandi A.
        Transurethral incision of the prostate.
        J Urol. 1973; 110: 229-231
        • Kletscher B.A.
        • Oesterling J.E.
        Transurethral incision of the prostate: a viable alternative to transurethral resection.
        Semin Urol. 1992; 10: 265-272
        • Abrams P.
        • Chapple C.
        • Khoury S.
        • et al.
        Evaluation and treatment of lower urinary tract symptoms in older men.
        J Urol. 2009; 181: 1779-1787
        • McVary K.T.
        • Roehrborn C.G.
        • Avins A.L.
        • et al.
        Update on AUA guideline on the management of benign prostatic hyperplasia.
        J Urol. 2011; 185: 1793-1803
        • Glass A.S.
        • McAninch J.W.
        • Zaid U.B.
        • et al.
        Urethroplasty after radiation therapy for prostate cancer.
        Urology. 2012; 79: 1402-1405
        • Bullock T.L.
        • Brandes S.B.
        Adult anterior urethral strictures: a national practice patterns survey of board certified urologists in the United States.
        J Urol. 2007; 177: 685-690
        • Gómez-Iturriaga Piña A.
        • Crook J.
        • Borg J.
        • et al.
        Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged < or = 55 years with favorable prostate cancer.
        Urology. 2010; 75: 1412-1416
        • Elliott S.P.
        • McAninch J.W.
        • Chi T.
        • et al.
        Management of severe urethral complications of prostate cancer therapy.
        J Urol. 2006; 176: 2508-2513
        • Meeks J.J.
        • Brandes S.B.
        • Morey A.F.
        • et al.
        Urethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experience.
        J Urol. 2011; 185: 1761-1765
        • Eisenberg M.L.
        • Elliott S.P.
        • McAninch J.W.
        Preservation of lower urinary tract function in posterior urethral stenosis: selection of appropriate patients for urethral stents.
        J Urol. 2007; 178: 2456-2460
        • Park R.
        • Martin S.
        • Goldberg J.D.
        • et al.
        Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence.
        Urology. 2001; 57: 742-746
        • Herschorn S.
        • Carrington E.
        S-shaped coaxial dilators for male urethral strictures.
        Urology. 2007; 69: 1199-1201
        • Ramchandani P.
        • Banner M.P.
        • Berlin J.W.
        • et al.
        Vesicourethral anastomotic strictures after radical prostatectomy: efficacy of transurethral balloon dilation.
        Radiology. 1994; 193: 345-349
        • Geary E.S.
        • Dendinger T.E.
        • Freiha F.S.
        • et al.
        Incontinence and vesical neck strictures following radical retropubic prostatectomy.
        Urology. 1995; 45: 1000-1006
        • Popken G.
        • Sommerkamp H.
        • Schultze-Seemann W.
        • et al.
        Anastomotic stricture after radical prostatectomy: incidence, findings and treatment.
        Eur Urol. 1998; 33: 382-386
        • Hayashi T.
        • Yoshinaga A.
        • Ohno R.
        • et al.
        Successful treatment of recurrent vesicourethral stricture after radical prostatectomy with holmium laser: report of three cases.
        Int J Urol. 2005; 12: 414-416
        • Lagerveld B.W.
        • Laguna M.P.
        • Debruyne F.M.
        • et al.
        Holmium:YAG laser for treatment of strictures of vesicourethral anastomosis after radical prostatectomy.
        J Endourol. 2005; 19: 497-501
        • Eltahawy E.
        • Gur U.
        • Virasoro R.
        • et al.
        Management of recurrent anastomotic stenosis following radical prostatectomy using holmium laser and steroid injection.
        BJU Int. 2008; 102: 796-798
        • Chiou R.K.
        • Howe S.
        • Morton J.J.
        • et al.
        Treatment of recurrent vesicourethral anastomotic stricture after radical prostatectomy with endourethroplasty.
        Urology. 1996; 47: 422-425
        • Kuyumcuoglu U.
        • Eryildirim B.
        • Tarhan F.
        • et al.
        Antegrade endourethroplasty with free skin graft for recurrent vesicourethral anastomotic strictures after radical prostatectomy.
        J Endourol. 2010; 24: 63-67
        • Elliott D.S.
        • Boone T.B.
        Combined stent and artificial urinary sphincter for management of severe recurrent bladder neck contracture and stress incontinence after prostatectomy: a long-term evaluation.
        J Urol. 2001; 165: 413-415
        • Magera Jr., J.S.
        • Inman B.A.
        • Elliott D.S.
        Outcome analysis of urethral wall stent insertion with artificial urinary sphincter placement for severe recurrent bladder neck contracture following radical prostatectomy.
        J Urol. 2009; 181: 1236-1241
        • Yurkanin J.P.
        • Dalkin B.L.
        • Cui H.
        Evaluation of cold knife urethrotomy for the treatment of anastomotic stricture after radical retropubic prostatectomy.
        J Urol. 2001; 165: 1545-1548
        • Anger J.T.
        • Raj G.V.
        • Delvecchio F.C.
        • et al.
        Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management.
        J Urol. 2005; 173: 1143-1146
        • Wessells H.
        • Morey A.F.
        • McAninch J.W.
        Obliterative vesicourethral strictures following radical prostatectomy for prostate cancer: reconstructive armamentarium.
        J Urol. 1998; 160: 1373-1375
        • Vanni A.
        • Zinman L.
        • Buckley J.
        Management of recurrent bladder neck contractures with urethrotomy and mitomycin C [abstract].
        J Urol. 2010; 183: e426
        • Theodoros C.
        • Katsifotis C.
        • Stournaras P.
        • et al.
        Abdomino-perineal repair of recurrent and complex bladder neck-prostatic urethra contractures.
        Eur Urol. 2000; 38: 734-740
        • Herschorn S.
        Management of post-radical prostatectomy complete bladder neck occlusion [abstract].
        J Urol. 2007; 177: 14
        • Ullrich N.F.
        • Wessells H.
        A technique of bladder neck closure combining prostatectomy and intestinal interposition for unsalvageable urethral disease.
        J Urol. 2002; 167: 634-636